Abstract
8-(1-([1,1′-Biphenyl]-4-ylmethyl)piperidin-4-yl)-3,4-dihydroquinolin-2(1H)-one (1) and 8-(4-([1,1′- biphenyl]-4-ylmethyl)piperazin-1-yl)quinolin-2(1H)-one (2) are prepared in the crystalline state and studied by X-ray diffraction. The crystal packing drawing of compound (1) indicates that individual molecules are linked by pairs of N–H∙∙∙O hydrogen bonds forming A–A and B–B inversion dimers, with R22 (8) ring motifs. These dimers are stabilized by N–H∙∙∙O hydrogen bonds and linked via C–H∙∙∙O short contact interactions forming a two-dimensional network. In the case of compound (2), there are two independent molecules A and B linked by pairs of N–H∙∙∙O hydrogen bonds forming A–A and B–B inversion dimers, with R22 (8) ring motifs. These dimers are stabilized by N–H∙∙∙O hydrogen bonds and linked via C–H∙∙∙O short contact interactions forming a two-dimensional network.
This is a preview of subscription content, log in via an institution to check access.
References
M. Rowley, L. J. Bristow, and P. H. Hutson, J. Med. Chem., 44, No. 4, 477–501 (2001).
D. C. Goff and R. I. Shader, Non-Neurological Side-Effects of Antipsychotic Drugs, in: S. R. Hirsch and D. Weinberger (eds.), Schizophrenia. 2nd ed., Blackwell Publishing, Oxford (2002).
L. H. Lindstrom, Acta. Psychiatr. Scand. 77, No. 5, 524–529 (1988).
A. Newman-Tancredi, D. Cussac, and R. Depoortere, Curr. Opin. Invest. Drugs 8, No. 7, 539–554 (2007).
C. A. Jones and A. C. McCreary, Neuropharmacology 55, 1056–1065 (2008).
A. Newman-Tancredi, A. B. Assie, N. Leduc, A. M. Ormiere, N. Danty, and C. Cosi, Int. J. Neuropsychopharmacol. 8, 341–356 (2005).
M. B. Assie, V. Ravailhe, V. Faucillon, and A. Newman-Tancredi, J. Pharmacol. Exp. Ther., 315, 265–272 (2005).
L. Slot, L. D. Vries, A. Newman-Tancredi, and D. Cussac, Eur. J. Pharmacol. 534, 63–70 (2006).
L. Slot, M. S. Kleven, and A. Newman-Tancredi, Neuropharmacology 49, 996–1006 (2005).
M. S. Kleven, C. Barret-Grevoz, L. Slot, and A. Newman-Tancredi, Neuropharmacology 49, 135–143 (2005).
R. A. Bantick, J. F. W. Deakin, and P. M. Grasby, J. Psychopharmacol., 15, 37–46 (2001).
N. Ullah, Med. Chem. 10, 486–496 (2014).
N. Ullah, J. Enzyme Inhib. Med. Chem., 29, No. 2, 281–291 (2014).
N. Ullah and A. A. Al-Shaheri, Z. Naturforsch B, 67b, 75–84 (2012).
Stoe & Cie. X-Area V1.35 and X-RED32 V1.31 Software, Stoe & Cie GmbH, Darmstadt, Germany (2009).
G. M. Sheldrick, Acta Crystallogr. Sect A 64, 112–122 (2008).
A. L. Spek, Acta Crystallogr. Sect. D 65, 148–155 (2009).
C. F. Macrae, P. R. Edgington, P. McCabe, E. Pidcock, G. P. Shields, R. Taylor, M. Towler, and J. van de Streek, J. Appl. Crystallogr., 39, 453–457 (2006).
M. Altaf and H. Stoeckli-Evans, Acta Crystallogr. Sect C 66, o441–o445 (2009).
N. Ullah and H. Stoeckli-Evans, Acta Crystallogr. E 70, o103/o104 (2014).
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © 2017 N. Ullah, M. Altaf, M. Mansha.
The text was submitted by the authors in English. Zhurnal Strukturnoi Khimii, Vol. 58, No. 8, pp. 1747-1751, November-December, 2017.
Rights and permissions
About this article
Cite this article
Ullah, N., Altaf, M. & Mansha, M. Crystal structures of 1-aryl-4-(biarylmethylene)piperazine and piperidine, structurally related to adoprazine. J Struct Chem 58, 1697–1702 (2017). https://doi.org/10.1134/S0022476617080339
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0022476617080339